BREIJ; Esther
Patent Applications and Registrations
Patent applications and USPTO patent grants for BREIJ; Esther.The latest application filed is for "bispecific anti-cd37 antibodies, monoclonal anti-cd37 antibodies and methods of use thereof".
- BREIJ; Esther - Utrecht NL
| Patent | Date |
|---|---|
| Bispecific Anti-cd37 Antibodies, Monoclonal Anti-cd37 Antibodies And Methods Of Use Thereof App 20220251231 - OOSTINDIE; Simone ; et al. | 2022-08-11 |
| Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof Grant 11,396,553 - Oostindie , et al. July 26, 2 | 2022-07-26 |
| Axl-specific Antibodies For Treatment Of Non-small Cell Lung Cancer App 20210393793 - BREIJ; Esther ; et al. | 2021-12-23 |
| Anti-cd37 Antibodies And Anti-cd20 Antibodies, Compositions And Methods Of Use Thereof App 20210371539 - OOSTINDIE; Simone ; et al. | 2021-12-02 |
| Bispecific Anti-cd37 Antibodies, Monoclonal Anti-cd37 Antibodies And Methods Of Use Thereof App 20210355232 - OOSTINDIE; Simone ; et al. | 2021-11-18 |
| Anti-dr5 Antibodies And Methods Of Use Thereof App 20210324096 - OVERDIJK; Marije ; et al. | 2021-10-21 |
| Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof Grant 11,034,772 - Oostindie , et al. June 15, 2 | 2021-06-15 |
| Axl-specific Antibodies For Cancer Treatment App 20210070869 - JANMAAT; Maarten ; et al. | 2021-03-11 |
| Bispecific Anti-cd37 Antibodies, Monoclonal Anti-cd37 Antibodies And Methods Of Use Thereof App 20210024647 - OOSTINDIE; Simone ; et al. | 2021-01-28 |
| Anti-DR5 antibodies and methods of use thereof Grant 10,882,913 - Overdijk , et al. January 5, 2 | 2021-01-05 |
| Axl-specific Antibody-drug Conjugates For Cancer Treatment App 20200397913 - BOSHUIZEN; Julia ; et al. | 2020-12-24 |
| Bispecific Anti-cd37 Antibodies, Monoclonal Anti-cd37 Antibodies And Methods Of Use Thereof App 20200291124 - OOSTINDIE; Simone ; et al. | 2020-09-17 |
| Antibodies binding AXL Grant 10,765,743 - Breij , et al. Sep | 2020-09-08 |
| Bispecific Anti-cd37 Antibodies, Monoclonal Anti-cd37 Antibodies And Methods Of Use Thereof App 20200270359 - OOSTINDIE; Simone ; et al. | 2020-08-27 |
| Bispecific Antibodies Against Cd3 And Cd20 App 20200199231 - ENGELBERTS; Patrick ; et al. | 2020-06-25 |
| Antibodies Binding Axl App 20200171152 - BREIJ; Esther ; et al. | 2020-06-04 |
| Bispecific antibodies against CD3 and CD20 Grant 10,544,220 - Engelberts , et al. Ja | 2020-01-28 |
| Antibodies binding AXL Grant 10,512,688 - Breij , et al. Dec | 2019-12-24 |
| Antibodies binding AXL Grant 10,500,276 - Breij , et al. Dec | 2019-12-10 |
| Multispecific Antigen-binding Molecule With Improved Internalization Characteristics App 20190352423 - DE GOEIJ; Bart ; et al. | 2019-11-21 |
| Anti-dr5 Antibodies And Methods Of Use Thereof App 20190315877 - OVERDIJK; Marije ; et al. | 2019-10-17 |
| Antibodies Binding Axl App 20190275149 - BREIJ; Esther ; et al. | 2019-09-12 |
| Antibodies Binding Axl App 20190160170 - Breij; Esther ; et al. | 2019-05-30 |
| Anti-dr5 Antibodies And Methods Of Use Thereof App 20190144554 - OVERDIJK; Marije ; et al. | 2019-05-16 |
| Antibodies binding AXL Grant 10,201,607 - Breij , et al. Feb | 2019-02-12 |
| Axl-specific Antibody-drug Conjugates For Cancer Treatment App 20190022243 - BOSHUIZEN; Julia ; et al. | 2019-01-24 |
| Axl-specific Antibody-drug Conjugates For Cancer Treatment App 20180326084 - BOSHUIZEN; Julia ; et al. | 2018-11-15 |
| Antibodies Binding Axl App 20180214549 - BREIJ; Esther ; et al. | 2018-08-02 |
| Bispecific Antibodies Against Cd3 And Cd20 App 20170355767 - ENGELBERTS; Patrick ; et al. | 2017-12-14 |
| Antibodies Binding Axl App 20170157250 - BREIJ; Esther ; et al. | 2017-06-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 